TY - JOUR
T1 - Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex
AU - Bharadwaj, Mandvi
AU - Illing, Patricia
AU - Theodossis, Alex
AU - Purcell, Anthony W
AU - Rossjohn, Jamie
AU - McCluskey, James
PY - 2012
Y1 - 2012
N2 - The human leukocyte antigen (HLA) genes are the most polymorphic in the human genome and are critical in regulating specific immunity, hence their historical discovery as immune response genes. HLA allotypes are also implicated in unwanted immune reactions, including drug hypersensitivity syndrome (DHS), in which small therapeutic drugs interact with antigenic peptides to drive T cell responses restricted by host HLA. Abacavir, allopurinol, and carbamazepine are three commonly used drugs that cause a T cell-mediated hypersensitivity that is HLA linked, with each drug exhibiting striking specificity for presentation by defined HLA allotypes. Recent findings have begun to unearth the mechanistic basis for these HLA associations, and here we review recent advances in the field of HLA-associated drug hypersensitivities.
AB - The human leukocyte antigen (HLA) genes are the most polymorphic in the human genome and are critical in regulating specific immunity, hence their historical discovery as immune response genes. HLA allotypes are also implicated in unwanted immune reactions, including drug hypersensitivity syndrome (DHS), in which small therapeutic drugs interact with antigenic peptides to drive T cell responses restricted by host HLA. Abacavir, allopurinol, and carbamazepine are three commonly used drugs that cause a T cell-mediated hypersensitivity that is HLA linked, with each drug exhibiting striking specificity for presentation by defined HLA allotypes. Recent findings have begun to unearth the mechanistic basis for these HLA associations, and here we review recent advances in the field of HLA-associated drug hypersensitivities.
UR - http://www.annualreviews.org/doi/pdf/10.1146/annurev-pharmtox-010611-134701
U2 - 10.1146/annurev-pharmtox-010611-134701
DO - 10.1146/annurev-pharmtox-010611-134701
M3 - Article
VL - 52
SP - 401
EP - 431
JO - Annual Review of Pharmacology and Toxicology
JF - Annual Review of Pharmacology and Toxicology
SN - 0362-1642
ER -